Insulin rapidly stimulates tyrosine phosphorylation ofa protein of -185 kD in most cell types. This protein, termed insulin receptor substrate-I (IRS-1), has been implicated in insulin signal transmission based on studies with insulin receptor mutants. In the present study we have examined the levels of IRS-1 and the phosphorylation state ofinsulin receptor and IRS-1 in liver and muscle after insulin stimulation in vivo in two rat models of insulin resistance, i.e., insulinopenic diabetes and fasting, and a mouse model of non-insulin-dependent diabetes mellitus (ob/ob) by immunoblotting with anti-peptide antibodies to IRS-1 and anti-phosphotyrosine antibodies. As previously described, there was an increase in insulin binding and a parallel increase in insulin-stimulated receptor phosphorylation in muscle of fasting and streptozotocin-induced (STZ) diabetic rats. There was also a modest increase in overall receptor phosphorylation in liver in these two models, but when normalized for the increase in binding, receptor phosphorylation was decreased, in liver and muscle of STZ diabetes and in liver of 72 h fasted rats. In the hyperinsulinemic ob/ob mouse there was a decrease in insulin binding and receptor phosphorylation in both liver and muscle. The tyrosyl phosphorylation of IRS-1 after insulin stimulation reflected an amplification of the receptor phosphorylation in liver and muscle of hypoinsulinemic animals (fasting and STZ diabetes) with a twofold increase, and showed a significant reduction ('-50%) in liver and muscle of ob/ob mouse. By contrast, the levels of IRS-1 protein showed a tissue specific regulation with a decreased level in muscle and an increased level in liver in hypoinsulinemic states of insulin resistance, and decreased levels in liver in the hyperinsulinemic ob/ob mouse. These data indicate that: (a) IRS-1 protein levels are differentially regulated in liver and muscle; (b) insulin levels may play a role in this differential regulation of IRS-1; (c) IRS-1 phosphorylation depends more on insulin receptor kinase activity than IRS-1 protein levels; and (d) Insulin resistance is characteristic of many disease states including non-insulin-dependent diabetes mellitus (NIDDM),' uncontrolled insulin-dependent diabetes, obesity, and prolonged fasting (1-4). Although various defects in insulin action have been reported in these conditions, the exact mechanisms involved in the insulin resistance have not been adequately defined. Insulin initiates its metabolic and growth-promoting effects by binding to the a subunit of its tetrameric receptor (5), thereby activating the kinase in the ,B subunit, which in turn catalyzes the intramolecular autophosphorylation of specific tyrosine residues of the 13 subunit, further enhancing the tyrosine kinase activity of the receptor toward other protein substrates (5-7). Considerable evidence demonstrates that insulin receptor tyrosine kinase activity is essential for many, if not all, of the biological effects of insulin ( 8-10).
Insulin resistance is characteristic of many disease states including non-insulin-dependent diabetes mellitus (NIDDM),' uncontrolled insulin-dependent diabetes, obesity, and prolonged fasting (1) (2) (3) (4) . Although various defects in insulin action have been reported in these conditions, the exact mechanisms involved in the insulin resistance have not been adequately defined.
Insulin initiates its metabolic and growth-promoting effects by binding to the a subunit of its tetrameric receptor (5) , thereby activating the kinase in the ,B subunit, which in turn catalyzes the intramolecular autophosphorylation of specific tyrosine residues of the 13 subunit, further enhancing the tyrosine kinase activity of the receptor toward other protein substrates (5) (6) (7) . Considerable evidence demonstrates that insulin receptor tyrosine kinase activity is essential for many, if not all, of the biological effects of insulin (8) (9) (10) .
Although many purified proteins and synthetic peptides can be phosphorylated in vitro by isolated insulin receptors ( 11 ) , these reactions do not occur in vivo, and thus their physiological significance is uncertain. In most cells, insulin stimulates tyrosine phosphorylation of a cytoplasmic protein with a relative molecular mass between 165 and 185 kD, collectively called ppl 85 (12) (13) (14) (15) (16) (17) (18) (19) . Our laboratory recently cloned a component of the ppl 85 band termed insulin receptor substrate-1 (IRS-l ) (20) .
Although decreased insulin receptor kinase activity has been reported in various insulin resistant states, in most studies the receptors were partially purified, and then the kinase assays were performed in vitro using exogenous phosphoacceptor substrates such as histones (21) (22) (23) . Thus, the role of endogenous substrate for the insulin receptor, IRS-1, has not been examined in insulin-resistant states.
Taking advantage ofthe recent sequence data, we have prepared anti-peptide antibodies to IRS-1. By using these along with anti-phosphotyrosine antibodies, it is possible to directly assess insulin-stimulated tyrosine phosphorylation of both the insulin receptor and its substrate IRS-1. In the present study we examined the phosphorylation state of the receptor and IRS-1 after insulin stimulation in vivo and also the levels of this protein in liver and muscle in two hypoinsulinemic states with altered insulin action, i.e., insulinopenic diabetes and fasting, and in the hyperinsulinemic, insulin (Wilmington, MA) . Male obese hyperglycemic mice (C57B1 /6J ob/ob) and their lean matched controls (ob/+) were purchased from Jackson Laboratory (Bar Harbor, ME). Polyclonal anti-phosphotyrosine antibodies were raised in rabbits and affinity purified on phosphotyraminecolumnsasdescribedby Pangetal. (24) . Anti-IRS-l antibodies were raised in rabbits using a synthetic peptide derived from amino acid sequence (YIPGATMGTSPALTGDEAA) corresponding to residues 489-507 of the protein, and affinity purified on a column prepared by coupling the synthetic peptide to Affi-Gel 10 as previously described (25) .
Animals. Male rats (130-180 g) and mouse (6-8 wk) were fed standard rodent chow and water ad libitum. Food was withdrawn 12-14 h before experiments with the diabetic rats and ob/ob mouse and their respective controls. In the experiment on starvation, the rats were fed (controls) or fasted for 24, 48 , and 72 h. Diabetes was induced with streptozotocin (STZ) in citrate buffer, pH 4.5, administered intraperitoneally in a single dose of 100 mg/kg body wt to overnight fasted rats. Diabetic rats were studied 7 d after streptozotocin injection.
Methods. Rats and mice were anesthetized with sodium amobarbital ( 15 and 20 mg/kg of body weight intraperitoneally, respectively) and were used in experiments 10-15 min later, i.e., as soon as anesthesia was assured by loss of pedal and corneal reflexes. The abdominal cavity was opened, the portal vein was exposed, and 1 ml of normal saline (0.9% NaCI) with or without lO-5 M insulin was injected. At Approximately 2 min after injection, hindlimb muscles were quickly excised, and frozen in liquid nitrogen. At 4°C the frozen muscles were ground into a fine powder, then homogenized by a polytron in 6x vol ofhomogenization buffer B (same as buffer A except that 1% Triton-X 100 replaced 1% SDS and 2 mM PMSF and 0.1 mg/ml aprotinin were added). Both extracts were centrifuged at 55,000 rpm at 4°C in a model 70.1 Ti rotor (Beckman Instruments, Inc., Fullerton, CA) for 60 min to remove insoluble material, and the supernatant was used as a sample.
In preliminary experiments we showed that the maximal phosphorylation for IRS-I occurs between 30 and 60 s in liver and between I and 4 min in muscle after insulin infusion. The doses that give these maximal stimulation are 10-6 M and lI0-M insulin for liver and muscle, respectively. In that we infused into the portal vein I0O-M insulin and extracted liver at 30 s and muscle at 2 min, the tissue sampling was done at the peak of phosphorylation events.
In every disease state studied the livers were extracted in a way identical to that of muscle, and the supernatant solutions ofthe muscle and livers were used for immunoprecipitation with anti-IRS-l antibody. The samples were then treated with Laemmli sample buffer (26) with 100 mM DTT and heated in a boiling water bath for 4 min. For total extracts, similar size aliquots of sample (150 Mg of protein) were subjected to SDS-PAGE (6% Tris acrylamide) in a Bio-Rad Laboratories miniature slab gel apparatus (Mini-Protean). Molecular mass standards were myosin (205 kD), fl-galactosidase ( 1 16 kD), bovine serum albumin (80 kD), and ovalbumin (49.5 kD).
Electrotransfer of proteins from the gel to nitrocellulose was performed for 1 h at 90 V (constant) in the Bio-Rad Laboratories miniature transfer apparatus (Mini-Protean) as described by Towbin et al. (27) but with 0.02% SDS added to the transfer buffer to enhance elution of high molecular mass proteins. Nonspecific protein binding to the nitrocellulose was reduced by preincubating the filter overnight at 4VC in blocking buffer (3% BSA, 10 mM Tris, 150 mM NaCl, and 0.02% Tween 20) . The nitrocellulose blot was incubated with antiphosphotyrosine antibodies (apY 0.3 ug/ml) or with anti-IRS-I antibodies (ap8O 0.3 ug/ml) diluted in blocking buffer for 4 h at 220C and washed for 60 min with the blocking buffer without BSA. The blots were then incubated with 2 ,Ci of '25I-protein A (30 uCi/jig) in 10 ml of blocking buffer for I h at 220C and then washed again as described above for 2 h. '251I-protein A bound to the anti-phosphotyrosine and anti-IRS-I antibodies was detected by autoradiography using preflashed XAR film (Eastman Kodak Co., Rochester, NY) with Cronex Lightning Plus (DuPont Co., Wilmington, DE) intensifying screens at -70'C for 12-48 h. Band intensities were quantitated by optical densitometry (model GS 300; Hoefer Scientific Instruments, Inc., San Francisco, CA) of the developed autoradiogram.
Insulin binding. The purified plasma membrane fractions of liver and muscle were prepared as previously described (28) . The tissues were extracted from rats and mouse not injected with insulin. Aliquots of 200 Ml of purified plasma membrane (0.5 mg protein/ml) were incubated overnight at 4VC with 125I-insulin at 0.1-1 nM in the presence and absence of I x 10-5 M unlabeled insulin. The assay was terminated by centrifugation of the tubes at 9,000 g for 3 min. The pellets were washed twice by resuspension in washing buffer ( 150 mM NaCI, 50 nM Hepes, pH 7.4, and 1 mg/ml albumin) at 4°C, centrifuged, and the pellets were counted. Results are expressed as percentage of insulin bound compared to controls.
Cell culture. Chinese hamster ovary (CHO) cells that expressed high levels of surface insulin receptors (CHO/HIRC) (29) were cultured in 10-cm dishes (Nunc, Copenhagen, Denmark) in F12 medium supplemented with 10% fetal bovine serum (Gibco Laboratories, Grand Island, NY) at 37°C in a 5% CO2 incubator. For experiments, 90% confluent cultures (106 cells) were serum deprived for 14-16 h before hormone stimulation, extraction, and analysis. Insulin (final concentration l0-7 M) was added, and the incubation was continued at 37°C for 1 min. The cell monolayers were frozen with liquid nitrogen, thawed, and homogenized immediately with 2 ml of the same extraction buffer used to extract muscle. The cells were scraped from the dishes and insoluble material was sedimentated by centrifugation at 50,000 rpm in a model 70.1 Ti rotor for 60 min. The supernatant was treated with Laemmli sample buffer with 100 mM DTT and heated in a boiling water bath for 4 min. Equal aliquots ( 150 Mug of protein) of samples from CHO/HIRC cells and liver and muscle of rats injected with insulin were subjected to SDS-PAGE and immunoblotting with anti-IRS-I antibody as described above.
Other. Plasma glucose levels were determined with a Beckman Glucose Analyser (Beckman Instruments, Inc., Palo Alto, CA) on blood samples obtained when the animals were killed. Insulin was determined by a standard radioimmunoassay as previously described (30) . Protein determination was performed by the Bradford dye method (31 ) using the Bio-Rad Laboratories reagent and BSA as the standard.
Statistical analysis. Experiments were always performed studying the physiological or pathological group of animals in parallel with a control group. Comparisons between fed (0) and fasted (24-72 h), controls vs. diabetics, and ob/ + vs. ob/ob were made using paired and unpaired t test.
Results
Assay systems with anti-phosphotyrosine and anti-IRS-I antibodies. Fig. 1 A shows the phosphotyrosine proteins in rat liver and muscle before and after intraportal insulin injection. In the basal state a closely spaced doublet with molecular mass between 1 10 and 120 kD was observed in the SDS extracts of livers. We have referred to these bands collectively as pp1 20.
After intraportal insulin injection (10- (Fig. 1 B) . The apparent molecular mass of IRS-I was between 165 and 185 kD in CHO cells, between 150 and 165 kD in liver and between 165 and 175 kD in muscle. A similar molecular weight heterogeneity of IRS-I was also observed in mouse tissues (data not shown). The broad nature ofthe IRS-I band in CHO cells and liver resembles the broad bands observed with anti-phosphotyrosine antibodies.
To quantitate whether IRS-I is the only protein in the pp1 85 band, liver and muscle extracts from insulin-stimulated rats were subjected to multiple rounds of depletion of IRS-I with anti-IRS-I antibody (ap8O). Immunoprecipitated proteins were then solubilized in Laemmli sample buffer, reduced with 100 mM DTT, separated by 6% SDS-PAGE, transferred to nitrocellulose, and immunoblotted with anti-phosphotyrosine antibody and ap8O antibody. The results show that four rounds of depletion of IRS-I protein in liver using ap8O antibody removes over 98% of the IRS-1 /ppl85 protein as detected by anti-IRS-i and anti-phosphotyrosine antibodies. The results were very similar in muscle; after four rounds of depletion with ap8O, the band corresponding to ppi 85 represented only 0.4% of the original ppl 85 phosphoprotein. Furthermore, in both liver and muscle extracts, the depletion of IRS-I as measured by anti-phosphotyrosine and ap8O antibodies after each round of precipitation was almost identical. These data indicate that, at least in liver and muscle, IRS-I and pp 185 are the same protein. Ifthere are additional phosphotyrosine-containing proteins in the ppl85 band they represent < 2% and 0.5% of liver and muscle pp185, respectively.
Animal characteristics. Table I summarizes the body weight, plasma glucose, and serum insulin levels of animals in all studies. Rats starved for 24, 48, and 72 h showed a progress decrease in body weight from 172 to 139 g and a parallel decrease in the levels of plasma glucose and serum insulin. Rats rendered diabetic by streptozotocin were markedly hyperglycemic and hypoinsulinemic, and gained little or no weight over the 7 d. Plasma glucose and serum insulin levels, as well as the body weights, were markedly increased in the ob/ob mouse compared to the ob/+ control mice.
Effect offasting on insulin receptors and IRS-I phosphorylation in liver and muscle. Insulin binding to plasma membranes from liver and muscle was higher in fasted than in fed rats. In liver, the percent of labeled insulin bound increased by 21.5%, 37.7%, and 61% at 24, 48, and 72 h, respectively ( Fig. 2  C) . In muscle the time course and magnitude of change was similar (Fig. 3 C) . Previous studies have shown that this increase in binding is due to an increase in binding capacity rather than to an increase in binding affinity in these tissues (4, 32) .
During the 3 d of fasting there were no alterations in the constitutively phosphotyrosine-containing protein pp120 in liver (Fig. 2 A) . By comparison insulin-stimulated phosphorylation of the 95 kD # subunit ofthe insulin receptor increased.
Scanning densitometry revealed an increase of 17% (P < 0.05), 56% (P < 0.05), and 24% (P < 0.05) at 24, 48, and 72 h of fasting, respectively (Fig. 2 C) . When the data were corrected for the amount ofinsulin binding activity, there was no change in receptor phosphorylation per receptor in liver of rats fasted for 24 and 48 h, and a 23% decrease (P < 0.05) after 72 h of fasting.
Insulin-stimulated phosphorylation of IRS-1 increased during the 3 d of fasting (Fig. 2 A) . Quantitation ofthese data and those of similar experiments revealed a stepwise increase by 32.5% (P < 0.05), 71.7% (P < 0.001 ), and finally 94.7% (P < 0.01 ) each day during the fast ( Fig. 2 D) . After immunoprecipitation with ap8O and immunoblotting with anti-phosphotyrosine antibody there was also a clear increase in IRS-1 phos- phorylation after 3 d of fasting (Fig. 2 E) . Using the specific anti-peptide antibody (ap8O) against IRS-1, there was a slight but not statistically significant increase in the level of IRS-in liver during the fasting period. Acute insulin stimulation had no effect on IRS-1 protein levels. This was confirmed by scanning densitometry (Fig. 2 D) .
The effect ofstarvation on phosphotyrosyl proteins in muscle was similar to that in liver (Fig. 3 A) . By comparison ofthe lanes after insulin stimulation, there was an increase in the ,3 subunit phosphorylation of 26.2% (P < 0.05) at 24 h, 41.9% at 48 h, and 36.2% (P < 0.05) at 72 h of fasting (Fig. 3 C) . When the data were corrected for the amount of insulin binding, phosphorylation per receptor in muscle during the 3 d of fasting did not change significantly. Fig. 3 A also shows an increase in insulin-stimulated IRS-1 phosphorylation in skeletal muscle during the 3 d of fasting. The increase was almost maximal at 24 h (84.2%, P < 0.05) and then only increased slightly to 104% (P < 0.025) over the next 2 d (Fig. 3 D) . The increase in the phosphorylation of IRS-1 during the fasting was also demonstrated in an experiment in which the samples from muscle were immunoprecipitated with anti-IRS-1 antibody and analyzed by immunoblotting with anti-phosphotyrosine antibody (Fig. 3 E) . By contrast, there was a significant decrease in the level of IRS-I protein in muscle during starvation analyzed by immunoblotting with ap8O antibody with the lowest levels after 72 h of fasting (Fig. 3, B and D) . The decrease was by 29.7±10.5% (P < 0.05), 30.2±13.4% (P < 0.05), and 46.5±9.9% (P < 0.005) after 24, 48, and 72 h fasting, respectively (Fig. 3 D) .
Effect ofSTZ diabetes on insulin receptor and IRS-I phosphorylation in liver and muscle. The binding of 1251-insulin to plasma membranes from liver and muscle was higher in STZ diabetes as compared with controls (Fig. 4 C) . According to previous studies, this increase in binding in liver (21 ) and muscle (3) in STZ diabetes is primarily due to increased binding capacity rather than to a change in binding affinity. After insulin stimulation, the extent ofinsulin receptor autophosphorylation was similar in liver of control and diabetic rats (Fig. 4 A) .
In that insulin binding increases in diabetic rats, when the data are normalized for receptor binding activity, there was a decrease in receptor phosphorylation in liver of STZ diabetes by 43.5% (P < 0.01 ). Similarly, the phosphorylation ofIRS-1 also showed no significant increase in liver of diabetic rats after insulin stimulation (Fig. 4, A and D IRS-1 IRS-1 Phosphorylation Figure 3 . (A) Insulin-stimulated tyrosine phosphorylation in intact muscle from fed and fasted rats. The proteins from the skeletal muscle were isolated as described in Methods and processed as described in the legend to Fig. 1 lyzed by immunoblotting with anti-phosphotyrosine antibody (Fig. 5 E) . The levels of IRS-I protein were almost 30% higher in liver of diabetic rats as analyzed by immunoblotting with ap8O antibodies (Fig. 4, B and D) . Fig. 5 , A and B show immunoblotting of muscle samples from controls and diabetic rats analyzed with anti-phosphotyrosine and anti-IRS-1, respectively. 2 min after portal infusion of insulin, receptor autophosphorylation was 43% higher in diabetic muscles compared with controls (Fig. 5 C) . Again, when the data were corrected for the amount ofinsulin binding activity, there is a 29% (P < 0.05) decrease in receptor phosphorylation. The phosphorylation of IRS-1 also increased in muscle from diabetic rats by 106±38%. The extent of the increase in phosphorylation was higher in IRS-1 than in insulin receptor (106±38% vs. 43±19%). The muscle extracts that were immunoprecipitated with antibodies against IRS-1 and immunoblotted with anti-phosphotyrosine antibody also showed an increase in IRS-1 phosphorylation in samples from diabetic animals (Fig. 5 E) . The levels of IRS-1 analyzed by direct immunoblotting with ap8O antibodies showed a small ( 18%) but significant (P < 0.05) decrease in muscle from STZ diabetic rats (Fig. 5, B Insulin receptor and IRS-I phosphorylation in liver and muscle ofob/ob mice. There was a decrease in binding ofinsulin to plasma membranes from ob/ ob mouse liver and skeletal muscle (Fig. 6 C) . This decrease in insulin binding has been attributed to a decreased number of receptors rather than to a change in the affinity of insulin for its receptor (28, 33) .
As in the rat livers, the major, constitutively phosphotyrosine-containing protein in mouse liver was a closely spaced doublet M, 120 kD (Fig. 7 A) . After insulin infusion, the 95-kD insulin receptor fl subunit became phosphorylated. The extent of receptor autophosphorylation was only slightly decreased in the ob/ob diabetic mice compared with ob/+ controls (Fig. 6,  A and C) . Indeed, when corrected for insulin binding, there was a modest increase in receptor autophosphorylation in liver of ob/ob mice. The phosphorylation of IRS-1 band in liver of ob/ob mice was markedly reduced when compared to ob/+ controls (Fig. 6, A and D) . In some experiments, phosphorylated IRS-1 appeared as a closely spaced doublet in the liver extracts of ob/+ mice, whereas in samples from the ob/ob mice the upper band almost completely disappeared. The levels of IRS-I protein were also decreased by 34% (P < 0.025 ) in livers of ob/ob mouse compared to ob/+ controls (Fig. 6 , B and D).
In muscle, the level of insulin-stimulated phosphorylation of the insulin receptor # subunit was reduced by 40% in ob/ob mouse as compared to their lean controls (P < 0.05) (Fig. 7 , A and C). When these data were corrected for insulin binding, there was no change in insulin receptor phosphorylation in skeletal muscle of ob/ob mouse. The extent of phosphorylation of IRS-1 after insulin stimulation was decreased about 50% by scanning densitometry in ob/ob mouse compared to ob/ + controls (P < 0.01) (Fig. 7 D) . In samples previously immunoprecipitated with ap8O and immunoblotted with antiphosphotyrosine antibody also showed a major decrease in IRS-1 phosphorylation in liver and muscle of ob/ob mice (Figs. 6 E and 7 E). In the immunoblotting of muscle extracts of mouse with antibodies to IRS-1, the levels of IRS-1 protein appeared similar in ob/ + controls and ob/ob mouse (Fig. 7, B and D).
Discussion
Whereas the insulin receptor has been extensively characterized from a biochemical perspective, the exact molecular events linking the receptor tyrosine kinase to its cellular action are poorly understood. In most, if not all cells, insulin stimulates tyrosine phosphorylation of a cytoplasmic protein of relative molecular mass between 165 and 185 kD (12) (13) (14) (15) (16) (17) (18) (19) . This protein has been recently purified, cloned, and termed IRS-1 (20) , and shown to be a direct substrate ofthe insulin receptor in vivo and in vitro. Direct phosphorylation of IRS-1 by the activated insulin receptor can be demonstrated in vitro by incubation of baculovirus-produced IRS-1 with purified insulin receptor (Sun et al., manuscript submitted for publication).
The phosphorylation of IRS-1 is decreased in cells expressing a mutant insulin receptor, and the decrease correlates with defective insulin signaling (29) . This close correlation ofphosphorylation and insulin action and the novel structure ofthis protein with multiple tyrosine phosphorylation sites in Tyr-Met-XxxMet motif capable of interacting bearing SH2 domains (20) suggest an important role in insulin action. Although decreased insulin receptor kinase activity has been reported in various insulin-resistant states, the expression and phosphorylation of IRS-has not been examined in insulin-resistant states.
In the present study we have evaluated the role of insulin receptor kinase activation and receptor substrate tyrosine phosphorylation in the insulin signal transduction process in tissues of intact animals using anti-phosphotyrosine and anti-IRS-antibodies (25, 34) . In most prior animal studies ofinsulin receptor function, the receptors were first partially purified, and then in vitro kinase assays were performed using exogenous phosphoacceptor substrates (21, 35) . Although informative, the latter approach is susceptible to biochemical artifacts resulting from cell homogenization and receptor purification procedures, e.g., proteolysis (36) and/or dephosphorylation of the receptor by contaminating phosphoprotein phosphatases (37) , as well as removal ofthe receptor from the plasma membrane where interactions with other cellular components may influence receptor activity (38) . Furthermore, differences in receptor kinase activity may be manifest in vitro with certain specific phosphoacceptor substrate proteins, but not with others (39) . The method employed in this study is not subject to such complications and permits a direct assessment of insulin-stimulated tyrosine phosphorylation of the major endogenous substrate of potential physiological significance in small samples from diverse tissues type (25) . We have evaluated in vivo insulin stimulation tyrosine phosphorylation in three situations ofinsulin resistance: fasting, insulinopenic diabetes, and the obesity-associated insulin resistance. A summary of the results is presented in Table II. Prolonged fasting in rats is characterized by insulin deficiency and insulin resistance (4, 40) . In vivo both peripheral and hepatic insulin resistance on glucose metabolism have been observed (41) , despite an increase in insulin receptor number (32) . The mechanism by which insulin resistance occurs appears to differ from tissue to tissue. Insulin receptors solubilized and partially purified from 72-h fasting rats show a decrease insulin-stimulated autophosphorylation and exoge- 4) were extracted as described in Methods, and immunoprecipitated with anti-peptide 80 antibody. Samples from lanes 5 and 6 are aliquots of total extracts from the same sources of samples from lanes 2 and 4, respectively. All samples were resolved on 6% SDS-PAGE, transferred to nitrocellulose and detected with anti-phosphotyrosine antibody. M, bands given at right in A, B, and E are in kD.
nous tyrosine kinase activation in liver, but not in muscle (4) . Our results (normalized by total protein) showed an increase of 25% in insulin receptor autophosphorylation in liver and of 40% in muscle after 72 h of fasting. However, if we normalize the data tor insulin binding, they are in accordance with previous data that show a reduced receptor autophosphorylation (per receptor) in liver, but not in muscle after 72 h of fasting. By contrast, the in vivo phosphorylation of IRS-1 increases twofold in both liver and muscle after 72 h of fasting.
It is interesting that IRS-1 phosphorylation increases in both liver and muscle, whereas the level of IRS-I protein as determined by direct immunoblotting increases in liver but decreases in muscle during fasting (Table II) . The phosphorylation of IRS-1, the endogenous substrate of the insulin receptor kinase, which has been implicated in signal transmission (29) , is increased and parallels the increase in total receptor phosphorylation. The discrepancies between the actual quantitative magnitude of increase in # subunit phosphorylation and IRS-1 phosphorylation suggest that there may be amplification of the insulin-stimulated signal (i.e., tyrosine kinase activity) between a subunit autophosphorylation and the phosphorylation of IRS-1.
This increase in IRS-l (and total receptor) phosphorylation with fasting occurs despite a state of decreased insulin responsiveness in both liver and peripheral tissues of fasted animals (40) . The fact that euglycemic clamp studies show decreased insulin-stimulated glucose uptake in muscle in vivo with fasting suggests that tissue or circulating factors such as fatty acids, ketones, counterregulatory hormones, and acidosis may antagonize the stimulatory action of insulin on glucose transport in muscle as previously discussed (41) . It is possible that the increase in IRS-1 phosphorylation in liver and muscle during the 3-d fast could be a response to the impairment of insulin action.
Impaired insulin receptor kinase activation may play a role in the insulin resistance of insulinopenic diabetes. There is decreased kinase activity in receptors solubilized from muscle (3) and liver (21, 34) (3, 21, 34) . As in fasting, the increment in IRS-1 phosphorylation in muscle is higher than the increment in insulin receptor phosphorylation, consistent with an amplification ofthe insulin signal between , subunit autophosphorylation and the phosphorylation of IRS-1. Phosphorylation of IRS-1 increases almost twofold in muscle, but not in liver, of diabetic rats. Although the mechanism(s) responsible for this tissue specific regulation of insulin receptor and IRS-1 phosphorylation is not known, changes in the activity ofenzymes responsible for phosphotyrosine dephosphorylation may play a role. Our laboratory has previously shown (44) that there is an increase in both the particulate and cytosolic phosphotyrosine phosphatase activity in liver of rats made insulin-deficient diabetic by STZ. To our knowledge there is no report of phosphotyrosine phosphatase activity in muscle of STZ diabetic rats, but under most assay conditions, the levels of phosphotyrosine phosphatase are 10-fold higher in liver than in muscle (45 (Table II) . A well-studied rodent model of type 2 diabetes is the ob/ob mouse. This autosomal recessive mutation in mice is characterized by obesity, hyperglycemia, hyperinsulinemia, and several metabolic defects consistent with peripheral insulin insensitivity (46) . The decrease in insulin action in this model is associated with decreased receptor number (28, 33, 46) , but the activity of the receptor kinase against exogenous substrates, when corrected per insulin binding, appears to be normal (33, 47) . Thus the major defects in this model seem to be a decrease in the number ofinsulin receptors and alterations at the postreceptor level.
The current study show that in vivo there is a small decrease in insulin receptor autophosphorylation in liver and a modest decrease in muscle when normalized per milligram of protein. This completely disappears or is converted to an increase in liver, if we correct the data per insulin binding. In contrast there is a significant decrease in the level of tyrosine phosphorylation in IRS-I after insulin stimulation in liver and muscle in ob/ob mice suggesting that this may be a major factor in the insulin resistance. This is in accordance with a previous study that showed the absolute level of phosphorylation of ppl85 (IRS-1) in response to insulin is lower in adipocytes from NIDDM (48) .
Reduction in IRS-1 phosphorylation has also been observed in CHO cells expressing insulin receptors in which phenylalanine has been substituted for tyrosine 960 (29) or three phenylalanines for tyrosines 1158, 1162, and 1163 (8) . In the Phe-960 cells, the insulin binding and autophosphorylation are normal, and the absence ofbiological activity correlates specifically with the inability of the mutant receptor to stimulate the tyrosyl phosphorylation of IRS-1. This suggests that the phosphorylation ofcellular substrate IRS-I may be necessary for the biological activity of the insulin, even if receptor phosphorylation is normal. Thus, the reduced level of phosphorylation of IRS-I in liver and muscle in ob/ob mice may play a role in the impaired insulin action. The decreased level of IRS-I in liver may contribute to the reduction in tyrosyl phosphorylation of IRS-1, but in muscle the level of IRS-I protein is normal (Table II). Thus the decrease in IRS-I phosphorylation appears to reflect changes in the ability of the insulin receptor to utilize this protein substrate in these cells.
One question raised by the present study is whether IRS-I is heterogenous. The IRS-I band in the extracts of CHO cells, liver, and muscle migrate somewhat differently in SDS gels, and in mouse liver, IRS-I appears as two discrete bands, one of which is much more markedly decreased in the ob/ob mouse than the other. Our results using sequential immunoprecipitation demonstrate that IRS-I and ppl 85 are the same protein, at least in liver and muscle. It is likely that some ofthe differences in the apparent molecular mass are due to differences in serine, threonine, and/or tyrosine phosphorylation. When anti-IRS-1 antibodies were used to immunoprecipitate extracts of liver and muscle after insulin stimulation and analyzed by immunoblotting with anti-phosphotyrosine antibody, the behavior of IRS-1 phosphorylation was identical to that of the whole extract analyzed in the same blot for each of the conditions studied. Thus, IRS-1 and ppl 85 are the same and show identical changes in every disease state.
Taken together, the results of these three models of insulin resistance suggest that the level of tyrosine phosphorylation of IRS-I in muscle is increased in situations of hypoinsulinemia in spite ofdecreased level ofthe protein (Table II) . In liver, the phosphorylation of IRS-I also increases during fasting and STZ diabetes, and these two situations are accompanied by an increase in the level of the protein. On the other hand, in obesity-associated diabetes with hyperinsulinemia, the phosphorylation of IRS-I in liver and muscle is reduced, and this is associated with a decreased protein in liver. These data indicate that IRS-I has a tissue specific regulation, but that IRS-1 phosphorylation depends more on insulin receptor kinase activity than IRS-I protein levels. Our finding that the level of this protein in liver is inversely related to the insulin levels is striking and suggests that insulin may play a role in the regulation of IRS-I expression.
In summary, this study demonstrates that the insulin resistance observed in vivo in hypoinsulinemic states like fasting and STZ diabetes is associated with increased IRS-I phosphorylation in liver and muscle. Reduced IRS-I phosphorylation is present in liver and muscle of ob/ob mice and in this setting may play a role in the insulin-resistant state. The regulation of the IRS-I protein is tissue specific. In liver, insulin levels may also regulate the expression of IRS- 1. Further direct studies of the hormonal effect in protein expression are needed to clarify this point.
